All HIV articles – Page 5
-
NewsResearchers pinpoint most likely source of HIV rebound infection
Researchers used genetic sequencing techniques on the nonhuman primate version of HIV to identify that lymph nodes in the abdomen are the main source of rebound infection after the first week of stopping antiretroviral treatment.
-
NewsHIV ‘secret handshake’ helps it reach cell’s centre to kickstart infection
New research reveals how the HIV capsid gets into the nuclear pore barrier channel.
-
NewsScientists identify window of opportunity for treatment promoting HIV remission
Starting treatment four weeks after infection with HIV promotes long-term control of the virus following the interruption of treatment after two years of antiretroviral therapy.
-
NewsHIV antibodies protect animals in proof-of-concept study
Three different HIV antibodies each independently protected monkeys from acquiring simian-HIV (SHIV) in a placebo-controlled proof-of-concept study intended to inform development of a preventive HIV vaccine for people.
-
NewsAnti-HIV drugs may prevent complications from bacterial sepsis
A new study suggests that reverse transcriptase inhibitors — antiretroviral drugs also used to manage HIV infections — can be used to prevent inflammatory complications of bacterial sepsis.
-
NewsPriming vaccine tested by global project lays path to HIV vaccine
A global project is attemptng to discover a HIV vaccine based on germline targeting and that is practical for those in Low and Middle-Income Countries.
-
NewsSmallpox vaccine induces immunity against monkeypox infection in people living with HIV
Researchers have shown that intradermal vaccination with the JYNNEOS vaccine against smallpox is the best option to protect people living with HIV from contracting the monkeypox virus.
-
NewsHigher viral load during HIV infection can shape viral evolution
A new paper finds that HIV populations in people with higher viral loads also have higher rates of viral recombination.
-
NewsCalibr announces license agreement with Gilead to develop long-acting HIV antiviral agent
Long-acting combination HIV regimens have the potential to transform the future of coordinated HIV clinical care
-
NewsResearchers ID opportunities to improve future HIV vaccine candidates
An effective HIV vaccine may need to prompt strong responses from immune cells called CD8+ T cells to protect people from acquiring HIV, according to a new study.
-
NewsMpox vaccine triggers equally strong immune response in smaller doses
Delivering the two-dose mpox vaccine in smaller than the usual FDA-approved doses produced a detectable immune response. This also occurred regardless of whether people were living with or without HIV.
-
NewsScientists find new, better way to develop vaccines
Researchers have developed a new system to display epitopes in mammal cells for immunization studies and believe that this method can help scientists greatly in immunization efforts.
-
News40 years after the discovery of HIV, research raises hopes of remission
The conference ’40 years of HIV science’ was an opportunity to look back at the major advances that are raising hopes of remission and a cure for HIV.
-
NewsHIV drug could prevent coronaviruses, study finds
New research has shown how an HIV drug could stop many coronavirus diseases, including the SARS-CoV-2 variants, when given to infected cells at the right concentration.
-
NewsVery early antiretroviral therapy within hours of birth could suppress HIV in newborns
A study of more than 50 babies through 2 years old supports evidence that giving antiretroviral therapy (ART) to newborns with HIV within the first days of life can safely suppress amounts of HIV in the blood to undetectable levels.
-
NewsU/EEA: HIV diagnoses rise for the first time in a decade
The increase in 2022 can be attributed to several factors including restoring surveillance activities, scale-up and introduction of novel testing strategies in many countries, migration patterns, lifting of COVID-19 restrictions and arrival of refugees.
-
Long ReadsGender-specific approaches to HIV prevention: addressing the needs of women and girls
With nearly 25 million deaths and an estimated 33.2 million people (including 15.4 million women) living with the virus globally, HIV/AIDS is on the brink of becoming the most devastating pandemic the world has ever seen.
-
NewsHIV: Thwarting a protein in the hope of a better quality of life
The sustained activation of the body’s immune system for people living with HIV leads to chronic inflammation that can cause associated complications such as cardiovascular diseases, osteoporosis or neurocognitive decline.
-
NewsStudy uncovers mediators of persistent HIV viremia
Researchers examining people with non-suppressible HIV viremia (NSV) despite receiving antiretroviral therapy (ART) have found large reservoirs of proviruses inserted into transcriptionally active regions of immune cell genomes.
-
NewsCOVID-19 compromised U.S. gains in controlling HIV and worsened health disparities
The COVID-19 pandemic slowed previous gains made in controlling HIV blood levels and worsened health disparities, according to researchers leading the largest U.S. evaluation of the impact of the public health crisis on people with HIV.
